Alpine Associates Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Alpine Associates Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-925,000	Closed	-$19.8M	–	78
2026 Q1	$19.8M	Buy	+925,000	New	+$13M	1.17%	36

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alpine Associates Management's DAWN Position: Q2 2026 in Review

Alpine Associates Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 925,000 shares — an estimated $19.8M sold.

Alpine Associates Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $19.8M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Alpine Associates Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Alpine Associates Management sold 925,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $19.8M.
Alpine Associates Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Alpine Associates Management's Day One Biopharmaceuticals position peaked at $19.8M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Alpine Associates Management's 13F filing for Q2 2026, filed 6 Aug 2026.